FDA Receiving Many More Serious Adverse Events Reports (Medical News Today)
Between 1998 and 2005 the number of reports about serious adverse events sent to the Food and Drug Administration (FDA) has more than doubled; total deaths linked to adverse drug events have also more than doubled, according to an article in Archives of Internal Medicine (JAMA/Archives). [click link for full article]

FDA Accepts NDA Filing for Cleviprex(TM) (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute ... (Business Wire via Yahoo! Finance)
PARSIPPANY, N.J.----The Medicines Company today announced that the U.S. Food and Drug Administration has accepted the Company's new drug application for Cleviprex for the treatment of acute hypertension.